Munc13-3 antibody 126 303 from Synaptic Systems GmbH

Rudolf-Wissell-Str. 28

Goettingen 37079

Germany

Phone: +49-551-50556-0
+49-551-50556-384

(1) Chronic pharmacologic manipulation of dopamine transmission ameliorates metabolic disturbance in Trappc9-linked brain developmental syndromeJCI insightJune 18, 2024Li Y, Usman M, Sapp E, Ke Y, Wang Z, Boudi A, DiFiglia M, Li X.Trappc9 (1:500; Abcam, ab104041), TH (1:5,000, Abcam, ab137869), Unc13-3 (1:1,000, Synaptic Systems, 126303), Synpo1 (1:2,000, Novus Biologicals, NBP2-39100), PSD95 (1:1,000, Cell Signaling Technology, 2507S),

(2) Chronic Social Isolation Stress during Peri-Adolescence Alters Presynaptic Dopamine Terminal Dynamics via Augmentation in Accumbal Dopamine AvailabilityACS chemical neuroscienceApril 17, 2019Karkhanis AN, Leach AC, Yorgason JT, Uneri A, Barth S, Niere F, Alexander NJ, Weiner JL, McCool BA, Raab-Graham KF, et al.agitation at 4 °C overnight in a 1% solution of blocking buffer containing Munc13-3 primary antibody (126303; Synaptic Systems). Following extensive rinsing in Tris buffered saline/0.05% Tween-20, the membranes

Munc13-3 antibody